MA40520A - Fabrication et utilisation de protéine pc2 d'œuf hyperimmun - Google Patents

Fabrication et utilisation de protéine pc2 d'œuf hyperimmun

Info

Publication number
MA40520A
MA40520A MA040520A MA40520A MA40520A MA 40520 A MA40520 A MA 40520A MA 040520 A MA040520 A MA 040520A MA 40520 A MA40520 A MA 40520A MA 40520 A MA40520 A MA 40520A
Authority
MA
Morocco
Prior art keywords
manufacture
hyperimmune egg
invention refers
antigens
hyperimmune
Prior art date
Application number
MA040520A
Other languages
English (en)
Inventor
Constantin Chiurciu
Viorica Chiurciu
Iiuliana Mihai
Ionel Victor Patrascu
Georgiana Topilescu
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA40520A publication Critical patent/MA40520A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne la médecine, l'immunologie, des anticorps polyclonaux, des traitements préventifs et curatifs par immunisation passive et un soutien à la santé immunologique des patients âgés de plus de 60 ans et des patients immunodéprimés. La présente invention concerne un procédé de fabrication de "l'imunoinstant" polyvalent d'œuf hyperimmun. Cette invention concerne directement le procédé de fabrication de cet antigène complexe, hautement purifié, à partir du mélange de diverses souches bactérien
MA040520A 2014-10-29 2015-07-21 Fabrication et utilisation de protéine pc2 d'œuf hyperimmun MA40520A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201400810A RO130213A8 (ro) 2014-10-29 2014-10-29 Producerea şi folosirea oului hiperimun - pc2

Publications (1)

Publication Number Publication Date
MA40520A true MA40520A (fr) 2016-07-21

Family

ID=53188723

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040520A MA40520A (fr) 2014-10-29 2015-07-21 Fabrication et utilisation de protéine pc2 d'œuf hyperimmun

Country Status (4)

Country Link
EP (1) EP3212664A1 (fr)
MA (1) MA40520A (fr)
RO (1) RO130213A8 (fr)
WO (1) WO2016114677A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO130965A8 (ro) * 2015-10-16 2017-06-30 Romvac Company S.A. Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()
CN108992669B (zh) * 2018-08-27 2022-03-22 广州汇高生物科技有限公司 防治呼吸道感染的复合卵黄抗体组合物、雾化吸入溶液剂及制备工艺与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012666A1 (en) * 1998-11-05 2002-01-31 Hellen Chaya Greenblatt A method for increasing weight gain and feed efficiency
WO2000043019A2 (fr) * 1999-01-19 2000-07-27 Dcv Inc Composition anti-inflammatoire a base d'oeuf et methode de traitement et de prevention de l'inflammation
RO129645B1 (ro) * 2014-02-25 2022-05-30 Romvac Company S.A. PROCEDEU DE OBŢINERE A IMUNOGLO- BULINELOR IgY

Also Published As

Publication number Publication date
RO130213A8 (ro) 2017-06-30
WO2016114677A1 (fr) 2016-07-21
RO130213A0 (ro) 2015-05-29
EP3212664A1 (fr) 2017-09-06

Similar Documents

Publication Publication Date Title
IL273956A (en) Methods for preparing cells expressing chimeric antigen receptor
IL281819A (en) Chimeric antigen receptors and methods of making
IL320802A (en) Methods for administering chimeric antigen receptor immunotherapy
SG11202101825QA (en) Methods of making chimeric antigen receptor-expressing cells
IL288457A (en) Humanized anti-human CD19 antibodies and methods of use
IL252680A0 (en) A combination of Listeria-based vaccine and antibodies against tumor necrosis factor receptor 4 or 18
SG11201705293WA (en) Methods of making chimeric antigen receptor-expressing cells
SG11202100160SA (en) Uses of anti-bcma chimeric antigen receptors
SG11201705585QA (en) Anti-myostatin antibodies and methods of use
SG11201707886WA (en) Humanized anti-c1s antibodies and methods of use thereof
IL325567A (en) Methods of treatment using anti-il-17a/f antibodies
IL284026A (en) Methods for producing heterodimeric antibodies
GB201806072D0 (en) Methods of manufacture
DK3745851T3 (da) En akvakulturfremgangsmåde til fremstilling af lakseæg
MA40520A (fr) Fabrication et utilisation de protéine pc2 d'œuf hyperimmun
GB201805904D0 (en) Methods of Manufacture
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására
EP3231441A4 (fr) Nouvelle structure protéique produite par un anticorps efficace et utilisée pour l'immunisation
IL284086A (en) Controlled Fucosylation of Antibodies
IL250263A0 (en) An improved process for the preparation of immunoglobulin g (igg)
IL281635A (en) A synthetic method for the preparation of Alkoxymethylene-Benzoyllactonitrile
HK40036053A (en) Methods of administering chimeric antigen receptor immunotherapy
CA3258067A1 (en) Methods of making chimeric antigen receptor-expressing cells
SG10201608000TA (en) Method For The Preparation Of Immunoglobulins
ZA201606640B (en) Method for the preparation of immunoglobulins